NO743750L - - Google Patents
Info
- Publication number
- NO743750L NO743750L NO743750A NO743750A NO743750L NO 743750 L NO743750 L NO 743750L NO 743750 A NO743750 A NO 743750A NO 743750 A NO743750 A NO 743750A NO 743750 L NO743750 L NO 743750L
- Authority
- NO
- Norway
- Prior art keywords
- rifamycin
- water
- approximately
- temperature
- stated
- Prior art date
Links
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 claims description 22
- 229930189077 Rifamycin Natural products 0.000 claims description 21
- 229960003292 rifamycin Drugs 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- BTVYFIMKUHNOBZ-ZDHWWVNNSA-N Rifamycin S Natural products COC1C=COC2(C)Oc3c(C)c(O)c4C(=O)C(=CC(=O)c4c3C2=O)NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C BTVYFIMKUHNOBZ-ZDHWWVNNSA-N 0.000 claims description 13
- BTVYFIMKUHNOBZ-ODRIEIDWSA-N Rifamycin S Chemical compound O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-ODRIEIDWSA-N 0.000 claims description 13
- 230000007062 hydrolysis Effects 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- RAFHKEAPVIWLJC-OQQFTUDCSA-N Rifamycin O Natural products COC1C=COC2(C)Oc3c(C)c(O)c4C(=O)C(=CC5(OCC(=O)O5)c4c3C2=O)NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C RAFHKEAPVIWLJC-OQQFTUDCSA-N 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- RAFHKEAPVIWLJC-TWYIRNIGSA-N z67lem9p1w Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)N2)C)OC)C(C(=C3O)C)=C1C1=C3C(=O)C2=C[C@]11OCC(=O)O1 RAFHKEAPVIWLJC-TWYIRNIGSA-N 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000012736 aqueous medium Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HJYYPODYNSCCOU-ZDHWWVNNSA-N Rifamycin SV Natural products COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C)cc(O)c4c3C2=O HJYYPODYNSCCOU-ZDHWWVNNSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- BTVYFIMKUHNOBZ-QXMMDKDBSA-N rifamycin s Chemical class O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)\C=C/OC1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-QXMMDKDBSA-N 0.000 description 1
- 229940109171 rifamycin sv Drugs 0.000 description 1
- 229940081192 rifamycins Drugs 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000003799 water insoluble solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT31928/73A IT1043909B (it) | 1973-11-29 | 1973-11-29 | Procedimento di preparazione della rifamicina s per idrolisi della rifamicina o |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO743750L true NO743750L (da) | 1975-06-23 |
Family
ID=11234504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743750A NO743750L (da) | 1973-11-29 | 1974-10-17 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US3933801A (da) |
| JP (1) | JPS5084597A (da) |
| AR (1) | AR202328A1 (da) |
| AT (1) | AT333957B (da) |
| BE (1) | BE820517A (da) |
| CA (1) | CA1028323A (da) |
| CH (1) | CH605975A5 (da) |
| DD (1) | DD115123A5 (da) |
| DE (1) | DE2444527A1 (da) |
| DK (1) | DK133554B (da) |
| FI (1) | FI304374A (da) |
| FR (1) | FR2253021A1 (da) |
| GB (1) | GB1431034A (da) |
| HU (1) | HU167984B (da) |
| IT (1) | IT1043909B (da) |
| NL (1) | NL7414698A (da) |
| NO (1) | NO743750L (da) |
| RO (1) | RO63717A (da) |
| SE (1) | SE7413246L (da) |
| ZA (1) | ZA747071B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193919A (en) * | 1979-04-11 | 1980-03-18 | The Dow Chemical Company | Process for preparing rifamycin S using a strong acid cation exchange resin |
| CN103819487B (zh) * | 2014-02-07 | 2016-08-24 | 天津大学 | 一种利福平晶体及其制备方法 |
| CN106749327B (zh) * | 2017-01-24 | 2019-06-07 | 四川樵枫科技发展有限公司 | 利福霉素s晶体及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB924472A (en) * | 1959-08-07 | 1963-04-24 | Lepetit Spa | Antibiotics prepared from rifamycin b |
-
1973
- 1973-11-29 IT IT31928/73A patent/IT1043909B/it active
-
1974
- 1974-09-18 DE DE19742444527 patent/DE2444527A1/de active Pending
- 1974-09-23 FR FR7431987A patent/FR2253021A1/fr not_active Withdrawn
- 1974-09-30 BE BE149048A patent/BE820517A/xx unknown
- 1974-10-17 FI FI3043/74A patent/FI304374A/fi unknown
- 1974-10-17 NO NO743750A patent/NO743750L/no unknown
- 1974-10-18 GB GB4514474A patent/GB1431034A/en not_active Expired
- 1974-10-21 SE SE7413246A patent/SE7413246L/xx unknown
- 1974-10-21 DK DK550674AA patent/DK133554B/da unknown
- 1974-10-22 CA CA211,945A patent/CA1028323A/en not_active Expired
- 1974-10-22 HU HUAI242A patent/HU167984B/hu unknown
- 1974-10-23 DD DD181868A patent/DD115123A5/xx unknown
- 1974-10-24 US US05/517,834 patent/US3933801A/en not_active Expired - Lifetime
- 1974-10-25 AR AR256252A patent/AR202328A1/es active
- 1974-11-04 ZA ZA00747071A patent/ZA747071B/xx unknown
- 1974-11-07 AT AT891974A patent/AT333957B/de not_active IP Right Cessation
- 1974-11-11 NL NL7414698A patent/NL7414698A/xx unknown
- 1974-11-18 RO RO7400080523A patent/RO63717A/ro unknown
- 1974-11-21 JP JP49133203A patent/JPS5084597A/ja active Pending
- 1974-11-26 CH CH1566174A patent/CH605975A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AT333957B (de) | 1976-12-27 |
| RO63717A (fr) | 1979-01-15 |
| GB1431034A (en) | 1976-04-07 |
| CA1028323A (en) | 1978-03-21 |
| IT1043909B (it) | 1980-02-29 |
| ZA747071B (en) | 1975-11-26 |
| BE820517A (fr) | 1975-01-16 |
| DK133554C (da) | 1976-10-25 |
| DK133554B (da) | 1976-06-08 |
| FR2253021A1 (da) | 1975-06-27 |
| CH605975A5 (da) | 1978-10-13 |
| AR202328A1 (es) | 1975-05-30 |
| NL7414698A (nl) | 1975-06-02 |
| DK550674A (da) | 1975-07-28 |
| SE7413246L (da) | 1975-05-30 |
| HU167984B (da) | 1976-02-28 |
| US3933801A (en) | 1976-01-20 |
| DD115123A5 (da) | 1975-09-12 |
| FI304374A (da) | 1975-05-30 |
| DE2444527A1 (de) | 1975-06-12 |
| ATA891974A (de) | 1976-04-15 |
| JPS5084597A (da) | 1975-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Plimmer | Esters of phosphoric acid: Phosphoryl hydroxyamino-acids | |
| US4761472A (en) | Isolation and purification of hemin | |
| NO743750L (da) | ||
| SU668608A3 (ru) | Способ получени -кристаллической формы натриевой соли 7-( -2-формилокси-2-фенилацетамидо)-3-(1-метил-1н-тетразолил-5-тиометил)-3-цефем-4-карбоновой кислоты | |
| US5095115A (en) | Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone | |
| JPH0774186B2 (ja) | ５−アミノサリチル酸の製造方法 | |
| EP0450684B1 (en) | A process for the preparation of D-(-)-4-hydroxyphenylglycine and L-(+)-4-hydroxyphenylglycine, starting from D.L.-4-hydroxyphenylglycine | |
| CA1064518A (en) | Process for the preparation of an acetamide derivative | |
| SU1351915A1 (ru) | Способ получени госсипола из антранилата госсипола | |
| SU543355A3 (ru) | Способ получени производных глюкозы | |
| US3038908A (en) | Novel derivative of the tetracycline antibiotics | |
| US3879409A (en) | Isolation of 6-aminopenicillanic acid and salts thereof | |
| US3983109A (en) | Process for recovering cephalosporin C from A fermentation broth as the N-(p-nitrobenzoyl) derivative | |
| US4010167A (en) | Method for the recovery of zearalenone | |
| US4070363A (en) | Manufacture of tetramisole | |
| US2430946A (en) | Purification of penicillin | |
| US3798212A (en) | Resolution of benzodiazepine derivatives | |
| US2423062A (en) | Resolution of alpha-hydroxy-beta:beta-dimethyl-gamma-butyrolactone | |
| SU462817A1 (ru) | Способ получени 3,3"-диамино-4,4дицианодифенилоксида | |
| CN109912466B (zh) | 一种回收樟脑磺酸的方法 | |
| KR820001179B1 (ko) | 6-메톡시-α-메틸-2-나프탈렌초산 라세미체를 그의 대장체로 분할하는 방법. | |
| SU493472A1 (ru) | Способ получени эфиров 5/6/-карбоновых кислот 2-арилбензимидазола | |
| US3911113A (en) | Recrystallization process for the purification of nystatin | |
| SU478008A1 (ru) | Способ получени аденозин 21,31-циклофосфата | |
| CN116676358A (zh) | 一种2-氟-2-脱氧尿苷的制备方法 |